Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Osteoporosis drug cuts vertebral fractures in over-50s

Strontium ranelate can reduce the risk of vertebral fracture in young postmenopausal women, a European study suggests.

The Spinal Osteoporosis Therapeutic Intervention study, in 353 postmenopausal women aged 50-65 with severe osteoporosis, randomised patients to strontium ranelate 2g a day or placebo.

Over four years of follow-up, strontium ranelate reduced the risk of vertebral fracture by 35% and increased bone mineral density from baseline by 15.8% at the lumbar spine and 7.1% at the femoral neck.

Ann Rheum Dis 2008;67:1736-8

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say